Abstract
Pain therapies have traditionally been assessed using subjective rating scales of pain intensity. These rating scales can be influenced by external factors and may not capture improvements in the affective/motivational dimension of pain and related physical, mental, and social well-being [1,2]. Furthermore, the thoughts and behaviors associated with pain are believed to be more influential on disability and quality of life than the perception of pain itself [3]. In this clinical trial, commercially-available wearable biosensors are used to objectively monitor patient physiology and behaviors as alternative outcome measures across the patient’s journey from therapy trial through post-implant use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
